Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,114,900 | 250,000 | 339,400 | 4,293,600 | 337,700 |
| Marketable Securities | 16,000 | 1,000 | 1,000 | 2,500 | 2,500 |
| Receivables | 3,992,800 | 1,112,300 | 2,229,300 | 1,567,700 | 1,508,700 |
| Inventories | 3,125,100 | 984,600 | 2,627,300 | 1,633,300 | 1,726,300 |
| Income taxes - deferred | 600,800 | 477,000 | 278,500 | 203,400 | 277,200 |
| Other current assets | 143,500 | 3,806,900 | 124,700 | 37,600 | 294,900 |
| TOTAL | $11,017,200 | $7,110,600 | $6,252,300 | $8,272,900 | $4,540,700 |
| Non-Current Assets | |||||
| PPE Net | 2,797,900 | 283,400 | 1,704,300 | 1,532,900 | 1,581,300 |
| Investments And Advances | 518,300 | 153,300 | 233,300 | 164,600 | 145,200 |
| Intangibles | 125,027,500 | 36,988,300 | 45,134,000 | 15,709,400 | 16,031,600 |
| Other Non-Current Assets | 99,800 | 8,222,400 | 143,500 | 109,600 | 105,100 |
| TOTAL | $128,443,500 | $45,647,400 | $47,215,100 | $17,516,500 | $17,863,200 |
| Total Assets | $139,460,700 | $52,758,000 | $53,467,400 | $25,789,400 | $22,403,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,624,100 | N/A | 443,300 | 1,588,800 | 268,300 |
| Accounts payable and accrued liabilities | 5,820,100 | 3,030,100 | 3,937,500 | 2,443,100 | 2,323,800 |
| Other current liabilities | 17,400 | 2,142,500 | N/A | N/A | 204,700 |
| TOTAL | $7,655,500 | $5,247,500 | $4,481,300 | $4,183,400 | $3,002,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 42,700,500 | 14,837,700 | 15,093,800 | 10,742,600 | 8,452,200 |
| Deferred Revenues | 27,100 | N/A | 35,600 | 39,500 | 35,800 |
| aiOther Non-Current Liabilities | 2,202,500 | 1,583,500 | 1,319,600 | 460,300 | 537,201 |
| TOTAL | $60,395,700 | $19,175,000 | $19,841,100 | $11,921,300 | $9,773,201 |
| Total Liabilities | $68,051,200 | $24,422,500 | $24,322,400 | $16,104,700 | $12,775,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 392,445 | 266,252 | 265,061 | 264,261 | 174,447 |
| Retained earnings | -710,900 | -198,200 | 534,700 | 1,577,500 | 1,528,800 |
| Other shareholders' equity | -778,600 | -461,000 | -215,700 | 95,300 | 87,200 |
| TOTAL | $71,409,500 | $28,335,500 | $29,145,000 | $9,684,700 | $9,628,600 |
| Total Liabilities And Equity | $139,460,700 | $52,758,000 | $53,467,400 | $25,789,400 | $22,403,900 |